VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arte...
VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Pulmonary Arterial Hypertension (PAH) remains a therapeutic challenge, and the search continues for more effective drugs and drug combinations. We recently reported that deletion of the vasoactive intestinal peptide (VIP) gene caused the spontaneous expression of a PH phenotype that was fully corrected by VIP. The objectives of this investigation w...
Alternative Titles
Full title
VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_504e8353c71145329e7001f2d67bcb1e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_504e8353c71145329e7001f2d67bcb1e
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X,1465-9921
DOI
10.1186/1465-9921-12-141
